학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 249건 | 목록 1~10
Academic Journal
Schenker M; Sf Nectarie Oncology Center and University of Medicine and Pharmacy, Craiova, Romania.; Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile.; Richardet M; Fundación Richardet Longo, Instituto Oncológico de Córdoba, Córdoba, Argentina.; Ciuleanu TE; Department of Oncology, Oncology Institute Prof Dr Ion Chiricuta, Cluj-Napoca, Romania.; Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Schoffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.; Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Maio M; Department of Oncology, University of Siena and Center for Immuno-Oncology, Siena, Italy.; Lugowska I; Department of Early Phase Clinical Trials, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Lupinacci L; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.; Leary A; Université Paris-Saclay and Institut Gustave‑Roussy, Villejuif, France.; Delord JP; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse (IUCT)-Oncopole, Toulouse, France.; Grasselli J; Center for Medical Education and Clinical Research (CEMIC) University Hospital, Buenos Aires, Argentina.; Tan DSP; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Cancer Science Institute, National University of Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; NUS Centre for Cancer Research (N2CR), National University of Singapore, Singapore.; Friedmann J; Segal Cancer Center, Jewish General Hospital, Montreal, Québec, Canada.; Rossy Cancer Network, McGill University, Montreal, Québec, Canada.; Vuky J; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.; Tschaika M; Bristol Myers Squibb, Princeton, New Jersey, USA.; Konduru S; Bristol Myers Squibb, Princeton, New Jersey, USA.; Vemula SV; Bristol Myers Squibb, Princeton, New Jersey, USA.; Slepetis R; Bristol Myers Squibb, Princeton, New Jersey, USA.; Kollia G; Bristol Myers Squibb, Princeton, New Jersey, USA.; Pacius M; Bristol Myers Squibb, Princeton, New Jersey, USA.; Duong Q; Bristol Myers Squibb, Princeton, New Jersey, USA.; Huang N; Bristol Myers Squibb, Princeton, New Jersey, USA.; Doshi P; Bristol Myers Squibb, Princeton, New Jersey, USA.; Baden J; Bristol Myers Squibb, Princeton, New Jersey, USA.; Di Nicola M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy massimo.dinicola@istitutotumori.mi.it.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Dufau C; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Genais M; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Mucher E; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Jung B; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Garcia V; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Montfort A; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Tosolini M; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Clarke CJ; Stony Brook Cancer Center, and Department of Medicine, Stony Brook University, New York, NY, United States.; Medin JA; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States.; Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States.; Levade T; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Laboratoire de Biochimie, Institut Fédératif de Biologie, Centre Hospitalier Universitaire (CHU) Purpan, Toulouse, France.; Delord JP; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Oncopole Claudius Regaud, Toulouse, France.; Meyer N; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Service d'Oncodermatologie, Institut Universitaire du Cancer (IUCT-O), Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, France.; Pancaldi V; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Andrieu-Abadie N; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.; Ségui B; Unité Mixte de Recherche Intitut National de la Santé et de la Recherche Médicale (INSERM) 1037, Centre National de la Recherche Scientifique (CNRS) 5071, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse (CRCT), Toulouse, France.; Équipe labellisée Fondation Association (ARC), Toulouse, France.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Machiels JP; Institut Roi Albert II, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), UCLouvain, Brussels, Belgium. Electronic address: jean-pascal.machiels@saintluc.uclouvain.be.; Tao Y; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.; Licitra L; Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy.; Burtness B; Department of Medicine and Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.; Tahara M; National Cancer Center Hospital East, Kashiwa, Japan.; Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre and the University of Melbourne, Melbourne, VIC, Australia.; Alves G; Centro Integrado de Pesquisa em Oncologia, Hospital Nossa Senhora de Conceição, Porto Alegre, Brazil.; Lima IPF; CRIO-Centro Regional Integrado de Oncologia, Fortaleza, Brazil.; Hughes BGM; Royal Brisbane and Women's Hospital and University of Queensland, Brisbane, QLD, Australia.; Pointreau Y; Centre Jean Bernard, Institut Inter-Régional de Cancérologie, Centre de Cancérologie de la Sarthe, Le Mans, France.; Aksoy S; Hacettepe University Cancer Institute, Ankara, Turkey.; Laban S; Department of Otorhinology and Head and Neck Surgery, Ulm University Medical Center and Comprehensive Cancer Center Ulm, Ulm, Germany.; Greil R; Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT, Cancer Cluster Salzburg, Salzburg, Austria.; Burian M; Krankenhaus der Barmherzigen Schwestern Linz, Linz, Austria.; Hetnał M; Andrzej Frycz Modrzewski Krakow University, Amethyst Radiotherapy Centre, Rydygier Hospital, Krakow, Poland.; Delord JP; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Mesía R; Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.; Taberna M; Catalan Institute of Oncology, ONCOBELL, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Waldron JN; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada.; Simon C; CHUV University of Lausanne, Lausanne, Switzerland.; Grégoire V; Radiation Oncology Department, Centre Léon Bérard, Lyon, France.; Harrington KJ; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, National Institute of Health Research Biomedical Research Centre, London, UK.; Swaby RF; Merck & Co, Rahway, NJ, USA.; Zhang Y; Merck & Co, Rahway, NJ, USA.; Gumuscu B; Merck & Co, Rahway, NJ, USA.; Bidadi B; Merck & Co, Rahway, NJ, USA.; Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
Garralda E; Early Drug Development Unit, Vall d'Hebron, Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oh DY; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul National University College of Medicine, Seoul, Republic of Korea.; Italiano A; Early Phase Trials Unit, Institut Bergonié, Bordeaux, and Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Bedard PL; Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology & Hematology, University of Toronto, Toronto, Ontario, Canada.; Delord JP; Medical Oncology Department, IUCT Oncopole, Institut Claudius Regaud, Toulouse, France.; Calvo E; Centro Integral Oncológico Clara Campal, START Madrid - Clara Campal Comprehensive Cancer Center (CIOCC), Madrid, Spain.; LoRusso P; Yale Cancer Center, New Haven, CT, USA.; Wainberg Z; University of California Los Angeles, Los Angeles, CA, USA.; Cervantes A; Department of Medical Oncology, Hospital Clínico, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Rodriguez-Vida A; Hospital del Mar-CIBERONC, IMIM Research Institute, Barcelona, Spain.; Shemesh CS; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA.; Sane R; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA.; Mendus D; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA.; Ding H; Department of Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA.; Hendricks R; Department of BioAnalytical Sciences, Genentech, Inc., South San Francisco, CA, USA.; Meng R; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA.; Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.; Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Wu B; Early Drug Development Unit, Vall d'Hebron, Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul National University College of Medicine, Seoul, Republic of Korea.
Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Academic Journal
Cavillon A; Biostatistics & Health Data Science Unit, Institut Claudius Regaud - IUCT-Oncopole, Toulouse, France.; Pouessel D; Department of Medical Oncology, Institut Claudius Regaud - IUCT-Oncopole, Toulouse, France.; Houédé N; Institut de Cancérologie du Gard, CHU Nîmes, Nîmes Cedex, France.; Mathevet F; Biostatistics & Health Data Science Unit, Institut Claudius Regaud - IUCT-Oncopole, Toulouse, France.; Dauxois JY; Institut de Mathématiques de Toulouse, UMR 5219, Université de Toulouse, CNRS, INSA, Toulouse, France.; Chevreau C; Department of Medical Oncology, Institut Claudius Regaud - IUCT-Oncopole, Toulouse, France.; Culine S; Department of Medical Oncology, UCOG, AP-HP, Saint-Louis Hospital, Paris, France; Paris Curie University, Paris, France.; Delord JP; Department of Medical Oncology, Institut Claudius Regaud - IUCT-Oncopole, Toulouse, France.; Porcher R; Université Paris Cité, Centre de Recherche Épidémiologie et Statistiques (CRESS-UMR1153), INSERM, INRAE, Paris, France; Centre d'Épidémiologie Clinique, AP-HP, Hôtel-Dieu, Paris, France.; Filleron T; Biostatistics & Health Data Science Unit, Institut Claudius Regaud - IUCT-Oncopole, Toulouse, France. Electronic address: Filleron.thomas@iuct-oncopole.fr.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
Santoro A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele - Milan, Italy.; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Via Manzoni 56, Rozzano, Milan, Italy.; Assenat E; Hopital Arnaud de Villeneuve Montpellier Cedex 5, Herault, France.; Yau T; Department of Medicine, Queen Mary Hospital, Hong Kong, China.; Delord JP; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Maur M; Oncology Unit, AOU Policlinico Modena and University Study of Modena and Reggio Emilia, Modena, Italy.; Knox J; Princess Margaret Cancer Centre Toronto, ON, Canada.; Cattan S; CHRU de Lille-Hospital Claude Huriez, Lille Cedex, France.; Lee KH; Seoul National University Hospital, Seoul, South Korea.; Del Conte G; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.; Springfeld C; Nat. Centrum f. Tumorerkrankungen, Universitätsklinikum Heidelberg, Heidelberg, Germany.; Leo E; Novartis Pharma AG, Basel, Switzerland.; Xyrafas A; Novartis Pharma AG, Basel, Switzerland.; Fairchild L; Oncology Data Science, Novartis Institutes for BioMedical Research, Cambridge, USA.; Mardjuadi F; Novartis Institutes for Biomedical Research Co., Ltd., Shanghai, China.; Chan SL; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101761237 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5559 (Electronic) Linking ISSN: 25895559 NLM ISO Abbreviation: JHEP Rep Subsets: PubMed not MEDLINE
Academic Journal
Voissière A; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Gomez-Roca C; Department of Medical Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Chabaud S; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Rodriguez C; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Nkodia A; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Berthet J; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Montane L; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Bidaux AS; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Treilleux I; Biopathology Department, Centre Léon Bérard, Lyon, France.; Eberst L; Department of Medical Oncology, Centre Léon Bérard, 28 rue Laennec, Lyon, France.; Terret C; Department of Medical Oncology, Centre Léon Bérard, 28 rue Laennec, Lyon, France.; Korakis I; Department of Medical Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Garin G; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Pérol D; Clinical Research Platform (DRCI), Centre Léon Bérard, Lyon, France.; Delord JP; Department of Medical Oncology, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Caux C; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Dubois B; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Ménétrier-Caux C; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Bendriss-Vermare N; Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Centre Léon Bérard, Lyon, France.; Cassier PA; Department of Medical Oncology, Centre Léon Bérard, 28 rue Laennec, Lyon, France.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Laprie A; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.; Noel G; CANS, Strasbourg, France.; Chaltiel L; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Truc G; Centre Georges-François Leclerc, Dijon, France.; Sunyach MP; Centre Léon Berard, Lyon, France.; Charissoux M; Centre Val d'Aurelle, Montpellier, France.; Magne N; Institut de Cancérologie de la Loire, Saint-Priest en Jarez, France.; Auberdiac P; Clinique Claude Bernard, Albi, France.; Biau J; Centre Jean-Perrin, Clermont-Ferrand, France.; Ken S; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, RadOpt-CRCT-INSERM, Toulouse, France.; Tensaouti F; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole & ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.; Khalifa J; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Sidibe I; Centre Eugène Marquis, Rennes, France.; Roux FE; Centre Hospitalier Universitaire de Toulouse, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.; Vieillevigne L; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Catalaa I; Centre Hospitalier Universitaire de Toulouse, Toulouse, France.; Boetto S; Centre Hospitalier Universitaire de Toulouse, Toulouse, France.; Uro-Coste E; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, RadOpt-CRCT-INSERM, Toulouse, France.; Supiot S; Institut de Cancerologie de l'Ouest, Nantes st Herblain, France.; Bernier V; Institut de Cancérologie de Lorraine Centre Alexis Vautrin, Nancy, France.; Filleron T; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Mounier M; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Poublanc M; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Olivier P; Service de Pharmacologie Médicale et Clinique, Centre Régional de Pharmacovigilance, de Pharmacoépidémiologie et d'Information sur le Médicament CHU de Toulouse, Toulouse, France.; Delord JP; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Cohen-Jonathan-Moyal E; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, RadOpt-CRCT-INSERM, Toulouse, France.
Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Academic Journal
Marret G; Department of Drug Development and Innovation (D3i), Institut Curie, 26 Rue d'Ulm, 75005, Paris, France.; Temam S; Department of Head and Neck Surgery, Gustave Roussy, Villejuif, France.; Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, 26 Rue d'Ulm, 75005, Paris, France.; Even C; Head and Neck Oncology Department, Gustave Roussy, Villejuif, France.; Delord JP; Department of Medical Oncology, Centre Claudius Régaud, Toulouse, France.; Hoffmann C; Department of Head and Neck Surgery, Institut Curie, Paris, France.; Dolivet G; Department of Head and Neck Surgery, Institut de Cancérologie de Lorraine, Nancy, France.; Malard O; Department of Head and Neck Surgery, Centre Hospitalier Universitaire, Nantes, France.; Fayette J; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Capitain O; Department of Medical Oncology, Centre Paul Papin, Angers, France.; Vergez S; Department of Head and Neck Surgery, Institut Claudius Regaud, Toulouse, France.; Geoffrois L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy, France.; Rolland F; Department of Medical Oncology, Centre René Gauducheau, Nantes, France.; Zrounba P; Department of Head and Neck Surgery, Centre Léon Bérard, Lyon, France.; Laccourreye L; Department of Head and Neck Surgery, Centre Hospitalier Universitaire, Angers, France.; Saada-Bouzid E; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.; Aide N; Department of Nuclear Medicine, Centre François Baclesse, Caen, France.; Bénavent V; UNICANCER, Paris, France.; Klijianenko J; Department of Pathology, Institut Curie, Paris, France.; Lamy C; Department of Drug Development and Innovation (D3i), Institut Curie, 26 Rue d'Ulm, 75005, Paris, France.; Girard E; Bioinformatics Core Facility, INSERM U900, Mines Paris Tech, Institut Curie, Paris, France.; Vacher S; Genetics Department, Institut Curie, Paris, France.; Masliah-Planchon J; Genetics Department, Institut Curie, Paris, France.; de Koning L; Department of Translational Research, Institut Curie, PSL Research University, Paris, France.; Puard V; Department of Translational Research, Institut Curie, PSL Research University, Paris, France.; Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, 26 Rue d'Ulm, 75005, Paris, France.; Jimenez M; UNICANCER, Paris, France.; Bièche I; Genetics Department, Institut Curie, Paris, France.; Gal J; Department of Biostatistics, Centre Antoine Lacassagne, Nice, France.; Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, 26 Rue d'Ulm, 75005, Paris, France. christophe.letourneau@curie.fr.; INSERM U900, Institut Curie, Paris-Saclay University, Paris, France. christophe.letourneau@curie.fr.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Van Cutsem E; Digestive Oncology, University Hospitals Gasthuisberg, Leuven and KU Leuven, Leuven, Belgium.; Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Delord JP; Medical Oncology Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Tabernero J; Medical Oncology Department, Vall d'Hebron Campus Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UICC, Barcelona, Spain.; Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Ducreux M; Department of Medical Oncology, Gustave Roussy, Cancer Campus, Université Paris-Saclay, Villejuif, France.; Siena S; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Department of Oncology, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Elez E; Medical Oncology Department, Vall d'Hebron Campus Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Kasper S; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.; Zander T; Department of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne, University of Cologne, Duesseldorf, Germany.; Department of Internal Medicine I, Gastrointestinal Cancer Group Cologne (GCGC), University Clinic Cologne, Cologne, Germany.; Steeghs N; Department of Medical Oncology and Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Murphy D; Translational Oncology, Pfizer, La Jolla, CA, USA.; Edwards M; North American Medical Affairs, Pfizer, New York, NY, USA.; Wainberg ZA; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Delord JP
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어